Nitrosylated proteins in monocytes as a new marker of oxidative-nitrosative stress in diabetic subjects with macroangiopathy

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 2, 2009, Pages 72-77

  Julius, U ^a   Drel, V R ^b   Grassler J ^a   Obrosova, I G ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Diabetes mellitus; HbA1C; Lipids; Nitrosylated proteins; Plasma glucose

Indexed keywords

3 NITROTYROSINE; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C;

AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MONOCYTE; NITROSATIVE STRESS; NITROSYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

AGED; BIOLOGICAL MARKERS; BODY WEIGHT; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MONOCYTES; NITROGEN; OXIDATIVE STRESS; PROTEINS;

EID: 61849181013     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-2008-1078710     Document Type: Article

References (41)

1. Packer P, Beckman JS, LiaudetL. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424
2. Szabo C, Mabley JG, Moeller SM, Skimanovick R, Packer P, Virag L, Soriano FG, Duzer JH Van, Williams W, Salzman AL, Groves JT. Part I:pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol Med 2002;8:571-580
3. Virag L, Szabo E, Gergely P, Szabo C. Peroxynitrite-induced cytotoxicity:mechanism and opportunities for intervention. Toxicol Lett 2003;140-141:113-124
4. Packer P, Obrosova IG, Mabley JG, Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 2005;12:267-275
5. Obrosova IG, Packer P, Szabo C, Zsengeller Z, Hirooka H, Stevens MJ, Yorek MA. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes 2005;54:234-242
6. Kowluru RA, Kanwar M, Kennedy A. Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp Diabetes Res 2007;2007:21976
7. Drel VR, Packer P, Stevens MJ, Obrosova IG. Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells. Free Radic Biol Med 2006; 40: 1454-1465
8. Obrosova IG, Mabley JG, Zsengeller Z, Ckarniauskaya T, Abatan OI, Groves JT, Szabo C. Role for nitrosative stress in diabetic neuropathy:evidence from studies with a peroxynitrite decomposition catalyst.FASEBJ 2005;19:401-403
9. Drel VR, Masktalir N, Ilnytska O, Skin J, Li F, Lyzogubov W, Obrosova IG. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 2006;55:3335-3343
10. Vareniuk I, Pavlov IA, Drel VR, Lyzogubov W, Ilnytska O, Bell SR, Tibrewala J, Groves JT, Obrosova IG. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice. Exp Neurol 2007;205:425-436
11. Drel VR, Packer P, Vareniuk I, Pavlov I, Ilnytska O, Lyzogubov W, Tibrewala J, Groves JT, Obrosova IG. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice. Eur J Pharmacol 2007;569:48-58
12. Obrosova IG, Ilnytska O, Lyzogubov W, Pavlov IA, Masktalir N, Nadler JL, Drel VR. High-fat diet induced neuropathy of pre-diabetes and obesity:effects of "healthy" diet and aldose reductase inhibition. Diabetes 2007;56:2598-2608
13. Drel VR, Packer P, Vareniuk I, Pavlov IA, Ilnytska O, Lyzogubov W, Bell SR, Groves JT, Obrosova IG. Evaluation of the peroxynitrite decom-position catalyst Fe(III)tetra-mesitylporphyrin octasulfonate (FeTMPS) on peripheral neuropathy in a mouse model of Type 1 diabetes. Int J Mol Med 2007;20:783-792
14. Obrosova IG, Drel VR, Oltman CL, Masktalir N, Tibrewala J, Groves JT, Yorek MA. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am J Physiol Endocrinol Metab 2007, published online
15. Oltman CL, Rickou LI, Davidson EP, Coppey LJ, Lund DD, Yorek MA. Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 2006;291:H1780-H1787
16. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 2001;44:834-838
17. Ceriello A, Quagliaro L, Catone B, Pascon R, Piazzola M, Bais B, Marra G, Tonutti L, Taboga C, Motz E. Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 2002;25:1439-1443
18. Ceriello A, Assaloni R, Da Ros R, Maier A, Quagliaro L, Piconi L, Esposito K, Giugliano D. Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients. Diabetologia 2004;47:1535-1540
19. Szabo C, Zancki A, Komjati K, Packer P, Krolewski AS, Quist WC, LoGerfo FW, Horton ES, Veves A. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 2002;106:2680-2686
20. Frustaci A, Kajstura J, Ckimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P. Myocardial cell death in human diabetes. Circ Res 2000;87:1123-1132
21. Tkuraisingkam RC, Nott CA, Dodd SM, Yaqoob MM. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int 2000;57:1968-1972
22. Nangle MR, Cotter MA, Cameron NE. Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice. Eur J Pharmacol 2004;502:143-148
23. Zkeng L, Du Y, Miller C Gubitosi-Klug RA, Kern TS, Ball S, Berkowitz BA. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Dia-betologia 2007;50:1987-1996
24. Towbin H, Staekelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets:Procedure and some applications. Biotechnology 1992;24:145-149
25. Ceriello A, Piconi L, Esposito K, Giugliano D. Telmisartan shows an equivalent effect of vitamin C in further improving endothelial dysfunction after glycemia normalization in type 1 diabetes. Diabetes Care 2007;30:1694-1698
26. Assaloni R, Da Ros R, Quagliaro L, Piconi L, Maier A, Zuodar G, Motz E, Ceriello A. Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients. Diabetologia 2005;48:1919-1924
27. Ceriello A, Lusk CW, Darsow T, Piconi L, Corgnali M, Nanayakkara N, Frias JP, Maggs D. Pramlintide reduced markers of oxidative stress in the postprandial period in patients with type 2 diabetes. Diabetes Metab Res Rev 2007, published online
28. Ceriello A, Assaloni R, Da Ros R, Maier A, Piconi L, Quagliaro L, Esposito K, Giugliano D. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 2005:111:2518-2524
29. Joknson JB, Summer W, Cutler RG, Martin B, Hyun DH, Dixit VD, Pearson M, Nassar M, Tellejokan R, Maudsley S, Carlson O, Jokn S, Laub DR, Mattson MP. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 2007;42:665-674
30. Kowluru RA, Odenback S. Effect of long-term administration of alphalipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 2004;53:3233-3238
31. Iknat MA, Tkorpe JE, Kamat CD, Szabo C, Green DE, Warnke LA, Lacza Z, Cselenyak A, Ross K, Skakir S, Piconi L, Kaltreider RC, Ceriello A. Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. Diabetologia 2007;50:1523-1531
32. Marfella R D'Amico M, Esposito K, Baldi A, Filippo C Di, Siniscalcki M, Sasso FC, Portogkese M, Cirillo F, Cacciapuoti F, Carbonara O, Crescenzi B, Baldi F, Ceriello A, Nicoletti GF, DAndrea F, Verza M, Coppola L, Rossi F, Giugliano D. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques:effects of rosiglitazone treatment. Diabetes 2006;55:622-632
33. Hoeldtke RD, Bryner KD, MacNeill DR, Hobbs GR, Baylis C. Peroxynitrite versus nitric oxide in early diabetes. Am J Hypertens 2003;16 (9 Pt 1):761-766
34. VinikAI, UllalJ, Parson HK, Barlow PM, Casellini CM. Pioglitazone treatment improves nitrosative stress in type 2 diabetes. Diabetes Care 2006;29:869-876
35. Nourooz-Zadek J, Ziegler D, Sokr C, Betteridge JD, Knigkt J, Hotkersall J. The use of pholasin as a probe for the determination of plasma total antioxidant capacity. Clin Biochem 2006;39:55-61
36. Ziegler D, Sokr CG, Nourooz-Zadek J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 2004;27:2178-2183
37. Hotta N, Toyota T, Matsuoka K, Skigeta Y, Kikkawa R, Kaneko T, Takakaski A, Sugimura K, Koike Y, Iskii J, Sakamoto N, SNK-860 Diabetic Neuropathy Study Group. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy:a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care 2001;24:1776-1782
38. Sima AA, Calvani M, Mekra M, Amato A, Acetyl-L-Carnitine Study Group. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy:ananalysis of two randomized placebo-controlled trials. Diabetes Care 2005;28:89-94
39. Bril V, Buckanan RA. Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy. Diabetes Care 2006;29:68-72
40. Vinik AI, Tuckman M, Safirstein B, Corder C, Kirby L, Wilks K, Quessy S, Blum D, Grainger J, Wkite J, Silver M. Lamotrigine for treatment of pain associated with diabetic neuropathy:results of two randomized, double-blind, placebo-controlled studies. Pain 2007;128:169-179
41. Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G, Bastyr 3rd EJ, Wolka AM, Vinik AI. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care 2007;30:896-902